Nigeria Centre for Disease Control
Nigeria Centre for Disease Control (NCDC) is the national public health institute of Nigeria, with the mandate to lead the preparedness, detection, and response to infectious disease outbreaks and public health emergencies. The headquarters are in Abuja, Nigeria's capital.
History[edit]
The NCDC was established in the year 2011 in response to the challenges of public health emergencies and to enhance Nigeria’s preparedness and response to epidemics through prevention, detection, and control of communicable diseases. Its core mandate is to detect, investigate, prevent and control diseases of national and international public health importance.
Function[edit]
The primary functions of the NCDC include the provision of surveillance, epidemiological investigation, laboratory diagnosis, research, logistics, vaccination and emergency response to communicable diseases and other public health emergencies. The Centre also provides leadership and technical partnership to prevent, detect, and respond to infectious disease outbreaks.
Structure[edit]
The NCDC is led by a Director General who is assisted by a team of competent staff. The Centre has departments that handle various aspects of disease control including Surveillance and Epidemiology, Laboratory Services, Health Emergency Preparedness and Response, and Health Promotion.
Achievements[edit]
Since its establishment, the NCDC has successfully responded to several outbreaks of diseases in Nigeria including Lassa Fever, Meningitis, Yellow Fever, and more recently, the COVID-19 pandemic. The Centre has also been instrumental in the development and implementation of the National Action Plan for Health Security (NAPHS).
Challenges[edit]
Despite its achievements, the NCDC faces several challenges including inadequate funding, weak health infrastructure, and a shortage of skilled manpower. These challenges have sometimes hampered the Centre's ability to effectively respond to disease outbreaks and public health emergencies.
See also[edit]
References[edit]
External links[edit]
- Official website
-
Front view of the NCDC Headquarters
-
A lab scientist labelling a cryovial tube to aliquot suspected COVID-19 sample at the NCDC National Reference Laboratory
-
Logo of the Nigeria Centre for Disease Control
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian